| Mrs Amy Elizabeth Peters, PA-C | |
|
86th Mdg, Unit 3215, Apo, AE 09094 | |
| (314) 479-2002 | |
| Not Available |
| Full Name | Mrs Amy Elizabeth Peters |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 86th Mdg, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598045874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 0110003632 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy Elizabeth Peters, PA-C 86th Medical Group, Unit 3215, Apo, AE 09094 Ph: () - | Mrs Amy Elizabeth Peters, PA-C 86th Mdg, Unit 3215, Apo, AE 09094 Ph: (314) 479-2002 |
News Archive
UT Southwestern Medical Center is one of only two places in the world that offers a new, innovative and highly successful approach to breast reconstruction after a mastectomy.
A large-scale study has now shown that adult women with anorexia whose disorder is not too severe can be treated successfully on an out-patient basis. Even after conclusion of therapy, they continue to make significant weight gains.
More than 60 percent of breast cancer survivors report at least one treatment-related complication even six years after their diagnosis, according to a new study led by a researcher from the Perelman School of Medicine at the University of Pennsylvania.
With gold nanoparticles, DNA and some smart chemistry as their tools, scientists at Northwestern University have developed a simple "litmus test" for mercury that eventually could be used for on-the-spot environmental monitoring of bodies of water, such as rivers, streams, lakes and oceans, to evaluate their safety as food and drinking water sources.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced positive preclinical results for CTX-0294945 as an adjuvant therapy to the cancer drug Avastin (bevacizumab - Genentech/Roche). The data is presented today in a late breaking poster at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, USA.
› Verified 1 days ago
Jeffrey Robert Hartzell, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 86 Mdg, Unit 3215, Ramstein Ab, Apo, AE 09094 Phone: 314-480-4758 | |
Mr. Francis Edward Criss Jr., PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Hq, Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Phone: 910-907-8922 | |
Jason Mommaerts, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg, Unit 3215, Apo, AE 09094 Phone: 314-480-7520 | |
Ms. Nancy Marie Giunta, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: Lrmc, Cmr 402, Box 1917, Apo, AE 09180 Phone: 486-820-2 | |
Ms. Karyn Elizabeth Kagel, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 3310,0, Apo, AE 09180 Phone: 314-542-3918 | |
Brandon Burt, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Us Army Meddac Bavaria, Cmr 411, Bldg 700, Rm 41, Apo, AE 09112 Phone: 734-787-1619 | |
Sean Kelly, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Cmr 411 Box 2507, Apo, AE 09112 Phone: 216-990-2375 |